Elements in support of the 'non-identity' of the PGRMC1 protein with the σ2 receptor

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• The sigma-2 (σ2) receptor is overexpressed in various human tumors, showing antiproliferative effects.
• σ2 receptor agonists are promising for cancer diagnosis and treatment, but the receptor's identity remains unconfirmed.
• Previous research suggested σ2 receptors are identical to progesterone receptor membrane component 1 (PGRMC1), a claim that is debated.

Purpose of the Study:

• To investigate the potential identity between the σ2 receptor and PGRMC1.
• To determine if PGRMC1 is the molecular target of σ2 receptor agonists.

Main Methods:

• Stable silencing and overexpression of PGRMC1 in MCF7 human adenocarcinoma cells.
• Western blotting to quantify PGRMC1 protein levels.
• Scatchard analysis with radioligands to determine σ2 receptor expression.
• Administration of σ2 ligands to assess antiproliferative effects in relation to PGRMC1 density.

Main Results:

• Western blotting confirmed altered PGRMC1 protein levels in the modified MCF7 cell lines.
• Scatchard analysis indicated distinct expression patterns for PGRMC1 and σ2 receptors.
• Antiproliferative effects of σ2 ligands did not directly correlate with PGRMC1 density.

Conclusions:

• The findings suggest that PGRMC1 and σ2 receptors are distinct molecular entities.
• This research contributes to clarifying the molecular identity of the σ2 receptor.
• The results challenge the proposed identification of σ2 receptors as PGRMC1.